LivaNova PLC
LIVN · XNASCIK 1639691fmd_1AGBWS81DWBTH0YPSX9879RYY9Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Apr 28, 2012 to Sep 30, 2026, 54 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 965 | 1,012 | 1,107 | 1,084 | 934 | 1,035 | 1,022 | 1,154 | 1,253 | 1,388 |
| Cost of revenue | 368 | 353 | 361 | 360 | 339 | 329 | 315 | 398 | 400 | 448 |
| Gross profit | 560 | 652 | 746 | 724 | 595 | 706 | 707 | 756 | 853 | 940 |
| Realized investment gains (losses) | – | – | – | 0 | 0 | 5 | 0 | 0 | 7 | (4) |
| Research and development | 82 | 110 | 146 | 147 | 153 | 183 | 156 | 194 | 183 | 186 |
| Selling, general and administrative | 355 | 380 | 465 | 528 | 447 | 472 | 469 | 503 | 509 | 549 |
| Total operating expenses | 528 | 556 | – | – | – | – | – | – | – | – |
| Operating income | 33 | 96 | (248) | (172) | (274) | (1) | (77) | (68) | 129 | 199 |
| Interest expense | 11 | 8 | 10 | 15 | 41 | 50 | 48 | 59 | 63 | 49 |
| Interest and investment income | 2 | 1 | 1 | 1 | 0 | 0 | 5 | 22 | 30 | 19 |
| Other non-operating income (expense) | – | – | – | – | – | – | 1 | 46 | 48 | (3) |
| Income before taxes | 26 | 121 | (247) | (188) | (348) | (124) | (75) | (81) | 88 | (221) |
| Income tax expense | 5 | 50 | (70) | (30) | (1) | 11 | 11 | (99) | 25 | 22 |
| Net income from continuing operations | 2 | 54 | (178) | (158) | (347) | (136) | (86) | 18 | 63 | (242) |
| Net income | (63) | (25) | (189) | (158) | (349) | (136) | (86) | 18 | 63 | (242) |